Drug shortages are causing medication errors, delayed or cancelled care, and prompting patient complaints, according to a survey of pharmacy directors published in the Journal of Managed Care Pharmacy.
Modern Medicine News
GSK's Mekinist and Tafinlar combination received accelerated approval after priority review.
As hospitals face decreased reimbursements, pharmacist involvement in pre- and post-discharge medication reconciliation is more important than ever.
Portola is pursuing accelerated approval for andexanet alfa and plans to initiate studies on a larger scale in 2014.
The law expands the powers of registered pharmacists and establishes a new category of Advanced Practice Pharmacists.
Since the NECC-triggered outbreak of fungal meningitis in 2012, FDA has responded aggressively, inspected almost 70 pharmacies. Now it is supported by a new law, the DQSA, and many new questions arise.
Some of the medications coming into Maine will originate in countries where oversight of the pharmaceutical production process is lax or nil. Are the possible consequences worth the probable savings?
Patch treating overactive bladder in women is now available OTC.
Three states prepare to handle mushrooming Medicaid enrollments
Two big causes drive NCPA's new president.